(R)evolution: toward a new paradigm of policy and patient advocacy for expanded access to experimental treatments
Crossref DOI link: https://doi.org/10.1186/s12916-016-0586-6
Published Online: 2016-02-29
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hogan, Melissa
License valid from 2016-02-29